on Sandoz Group AG (isin : CH1243598427)
Sandoz Joins Swiss Market Index After Stellar Growth
Basel, 9 July 2026 – Sandoz Group AG, renowned for its affordable medicines, is set to be part of Switzerland's leading equity index, the Swiss Market Index (SMI), as announced by SIX. This inclusion reflects Sandoz's impressive rise in the Swiss equity ranks since its 2023 listing.
The SMI, which includes the 20 largest and most liquid stocks on the SIX Swiss Exchange, will include Sandoz. This move symbolizes a triumphant period for the company, which has displayed robust growth and gained substantial investor confidence. CEO Richard Saynor highlighted that this milestone reflects the company's evolution and strategic direction.
CFO Remco Steenbergen pointed out the financial discipline and performance that have propelled Sandoz. The increased visibility will further bolster investment and value for stakeholders. The SMI's adjustments are set for 18 September 2026, with effects starting 21 September 2026.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Sandoz Group AG news